Dyskeratosis Congenita

Mayo Clin Proc. 2019 Sep;94(9):1668-1669. doi: 10.1016/j.mayocp.2019.04.032.

Authors

Eric T Stoopler¹, Rabie M Shanti²

Affiliations

¹ Department of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia. Electronic address: ets@upenn.edu.
² Department of Oral and Maxillofacial Surgery and Pharmacology, University of Pennsylvania School of Dental Medicine, Philadelphia; Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia.

PMID: 31486376
DOI: 10.1016/j.mayocp.2019.04.032

No abstract available

Publication types

Case Reports
Review

MeSH terms

Adolescent
Cell Cycle Proteins / genetics*
Diagnosis, Differential
Dyskeratosis Congenita / diagnosis*
Dyskeratosis Congenita / genetics*
Dyskeratosis Congenita / therapy
Female
Genetic Predisposition to Disease*
Graft vs Host Disease / diagnosis
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods
Humans
Monitoring, Physiologic
Nuclear Proteins / genetics*
Prognosis
Rare Diseases
Risk Assessment
Severity of Illness Index

Substances

Cell Cycle Proteins
DKC1 protein, human
Nuclear Proteins